NRF2-driven thiol metabolism creates a selective vulnerability to selenite
NRF2-driven metabolic changes may create vulnerabilities in certain lung cancers, making them potentially susceptible to selenite treatment.
Where it sits
this study against the rest of the glutathione (gsh) corpusSummary and findings
This study investigates the effects of NRF2-driven metabolic reprogramming on the vulnerability of non-small cell lung cancer cells to selenite. The research demonstrates that selenite can induce cell death in NRF2-hyperactive tumors. Notably, a selenite-rich diet suppressed tumor growth in mice.
Abstract
NRF2 hyperactivation caused by mutations in KEAP1 or NFE2L2 occurs in 20-30% of non-small cell lung cancers and confers therapy resistance. Here we show that NRF2-driven metabolic reprogramming creates a selective vulnerability to selenite. NRF2-dependent thiol export promotes the extracellular reduction of selenite to selenide. Our data support a model in which selenide enters cells and reaches mitochondria, where sulfide-quinone oxidoreductase uses selenide and glutathione to generate the selenopersulfide GS-SeH. A four-hour pulse of selenite was sufficient to induce cell death after washout, consistent with a selenium redox cycle that consumes NADPH and regenerates selenide. Within hours, selenite abolished aconitase activity and impaired mitochondrial respiration. The resulting cell death occurred independently of apoptosis, ferroptosis, pyroptosis, necroptosis and disulfidptosis. In mice, a selenite-rich diet selectively suppressed the growth of NRF2-hyperactive tumors. These findings identify an NRF2-driven metabolic vulnerability and support further investigation of selenite as a therapeutic strategy for NRF2-hyperactive cancers.
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Limitations
Not reported in abstract.